Zuo Jun Xu

721 total citations
18 papers, 483 citations indexed

About

Zuo Jun Xu is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Zuo Jun Xu has authored 18 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 4 papers in Physiology. Recurrent topics in Zuo Jun Xu's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Pulmonary Hypertension Research and Treatments (3 papers) and Viral-associated cancers and disorders (2 papers). Zuo Jun Xu is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Pulmonary Hypertension Research and Treatments (3 papers) and Viral-associated cancers and disorders (2 papers). Zuo Jun Xu collaborates with scholars based in China, United Kingdom and India. Zuo Jun Xu's co-authors include John A. Belperio, Robert M. Strieter, Ying Xue, Douglas A. Arenberg, Marie D. Burdick, Michael P. Keane, Hui Huang, Hui Li Zhang, Luca Richeldi and С. Н. Авдеев and has published in prestigious journals such as The Journal of Immunology, Medicine and BMC Medicine.

In The Last Decade

Zuo Jun Xu

18 papers receiving 468 citations

Peers

Zuo Jun Xu
Thomas A. Webb United States
Takakazu Higuchi Japan
Nathan Hambly Canada
Doaa Mohammed Youssef Egypt
Jens Helby Denmark
Rasmus Holmboe Dahl Denmark
Richa Gupta India
Sumru Beder Türkiye
Choonghyun Ahn South Korea
Mehmet Sinan Dal Türkiye
Thomas A. Webb United States
Zuo Jun Xu
Citations per year, relative to Zuo Jun Xu Zuo Jun Xu (= 1×) peers Thomas A. Webb

Countries citing papers authored by Zuo Jun Xu

Since Specialization
Citations

This map shows the geographic impact of Zuo Jun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuo Jun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuo Jun Xu more than expected).

Fields of papers citing papers by Zuo Jun Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuo Jun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuo Jun Xu. The network helps show where Zuo Jun Xu may publish in the future.

Co-authorship network of co-authors of Zuo Jun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zuo Jun Xu. A scholar is included among the top collaborators of Zuo Jun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuo Jun Xu. Zuo Jun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Richeldi, Luca, Adalberto Sperb Rubin, С. Н. Авдеев, Zarir Udwadia, & Zuo Jun Xu. (2021). Correction to: Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China. BMC Medicine. 19(1). 220–220. 1 indexed citations
2.
Xiang, Xiaoli, et al.. (2019). Cilostazol protects against myocardial ischemia and reperfusion injury by activating transcription factor EB (TFEB). Biotechnology and Applied Biochemistry. 66(4). 555–563. 19 indexed citations
3.
4.
Huang, Hui, Tao Lu, Shan Li, et al.. (2019). Association between clinicopathologic characteristics and BRAFV600E expression in Chinese patients with Langerhans cell histiocytosis. Thoracic Cancer. 10(10). 1984–1992. 3 indexed citations
5.
Lü, Lin, et al.. (2018). Cushing's disease with pulmonary Cryptococcus neoformans infection in a single center in Beijing, China: A retrospective study and literature review. Journal of the Formosan Medical Association. 118(1). 285–290. 4 indexed citations
6.
7.
8.
Li, Shan, et al.. (2016). Cardiac septic pulmonary embolism. Medicine. 95(25). e3846–e3846. 20 indexed citations
9.
Huang, Hui, et al.. (2016). A case report. Medicine. 95(27). e4113–e4113. 9 indexed citations
10.
Richeldi, Luca, Adalberto Sperb Rubin, С. Н. Авдеев, Zarir Udwadia, & Zuo Jun Xu. (2015). Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China. BMC Medicine. 13(1). 237–237. 32 indexed citations
11.
Huang, Hui, et al.. (2015). Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients. Medicine. 94(42). e1600–e1600. 30 indexed citations
12.
Li, Shan, et al.. (2015). Clinical Analysis of Pulmonary Nocardiosis in Patients With Autoimmune Disease. Medicine. 94(39). e1561–e1561. 16 indexed citations
13.
Li, Shan, Hui Huang, Jian Cao, et al.. (2015). Clinical spectrum of intrathoracic Castleman disease: a retrospective analysis of 48 cases in a single Chinese hospital. BMC Pulmonary Medicine. 15(1). 34–34. 34 indexed citations
14.
15.
Huang, Hui, et al.. (2014). A retrospective study of microscopic polyangiitis patients presenting with pulmonary fibrosis in China. BMC Pulmonary Medicine. 14(1). 8–8. 28 indexed citations
16.
Cao, Bin, et al.. (2003). [Clinical diagnosis, treatment and prognosis of elderly SARS patients].. PubMed. 25(5). 547–9. 2 indexed citations
17.
Wang, Zhong, et al.. (2003). [Clinical features and therapy of 106 cases of severe acute respiratory syndrome].. PubMed. 42(6). 373–7. 12 indexed citations
18.
Keane, Michael P., John A. Belperio, Douglas A. Arenberg, et al.. (1999). IFN-γ-Inducible Protein-10 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via Inhibition of Angiogenesis. The Journal of Immunology. 163(10). 5686–5692. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas A. Webb Breakdown of academic impact, for papers by Takakazu Higuchi Breakdown of academic impact, for papers by Nathan Hambly Breakdown of academic impact, for papers by Doaa Mohammed Youssef Breakdown of academic impact, for papers by Jens Helby Breakdown of academic impact, for papers by Rasmus Holmboe Dahl Breakdown of academic impact, for papers by Richa Gupta Breakdown of academic impact, for papers by Sumru Beder Breakdown of academic impact, for papers by Choonghyun Ahn Breakdown of academic impact, for papers by Mehmet Sinan Dal
Rankless by CCL
2026